Cortendo to raise up to $27.5 mln in private placement
Cortendo AB has agreed to receive up to $27.5 million in a private placement. The investors are RA Capital Management, New Enterprise Associates, Broadfin Capital and HealthCap. Headquartered in Göteborg, Sweden and with offices in Radnor, Pennsylvania, Cortendo is a biopharmaceutical firm focused on orphan endocrine disorders.
13 January 2015•4 mins read
